Pressure BioSciences’ Patented PCT Platform Shown to Significantly Improve Protein and DNA Detection in Multiple Studies

SOUTH EASTON, Mass., July 18, 2012 /PRNewswire via COMTEX/ — Pressure BioSciences, Inc. (otcqb:PBIO) (“PBI” or the “Company”) today announced that multiple research reports have cited the ability of the Company’s Pressure Cycling Technology (“PCT”) Platform to improve the detection of RNA, DNA, and/or protein in forensic, environmental, and biodefense applications, and in research studies focused on the discovery of biomarkers of disease. These studies were conducted in laboratories worldwide, including:

Institute of Forensic Sciences (Beijing, China) where scientists concluded that PCT was one of the most effective methods available for extracting DNA from bone in forensic applications. These findings extend earlier studies by other forensic scientists that PCT could lead to better methods of identification of crime victims and bodies of missing persons.

Comments are closed.